XML 42 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Acquisitions (Details) - USD ($)
3 Months Ended
Jan. 01, 2024
Nov. 02, 2016
Mar. 09, 2016
Mar. 31, 2017
Mar. 31, 2016
U.S. Rights to BIOCORNEUM          
Business Acquisition [Line Items]          
Cash     $ 6,859,000    
Deferred consideration     434,000    
Contingent consideration     116,000    
Total     $ 7,409,000    
U.S. Rights to BIOCORNEUM | Forecast          
Business Acquisition [Line Items]          
Number of years for future royalty payments to be paid 4 years 6 months        
U.S. Rights to BIOCORNEUM | Minimum          
Business Acquisition [Line Items]          
Estimated future payments due       $ 500,000  
U.S. Rights to BIOCORNEUM | General & administrative expense          
Business Acquisition [Line Items]          
Professional fees       0 $ 100,000
Tissue Expander Portfolio from SSP          
Business Acquisition [Line Items]          
Professional fees       0 $ 0
Cash   $ 4,950,000      
Contingent consideration   1,050,000      
Total   $ 6,000,000      
Tissue Expander Portfolio from SSP | Maximum          
Business Acquisition [Line Items]          
Estimated future payments due       $ 2,000,000